![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00435461 |
The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine
Condition | Intervention | Phase |
---|---|---|
Hayfever Allergic Rhinitis |
Drug: Fluticasone furoate and fexofenadine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Parallel Assignment, Efficacy Study |
Official Title: | A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis |
Estimated Enrollment: | 1000 |
Study Start Date: | December 2006 |
Ages Eligible for Study: | 12 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Exclusion criteria:
United States, Texas | |
GSK Investigational Site | |
San Antonio, Texas, United States, 78229 | |
GSK Investigational Site | |
Austin, Texas, United States, 78750 | |
GSK Investigational Site | |
Kerrville, Texas, United States, 78028 | |
GSK Investigational Site | |
San Antonio, Texas, United States, 78205 | |
GSK Investigational Site | |
New Braunfels, Texas, United States, 78130 | |
GSK Investigational Site | |
Austin, Texas, United States, 78731 |
Study Director: | GSK Clinical Trials, MD | GlaxoSmithKline |
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | FFU109045 |
Study First Received: | February 14, 2007 |
Last Updated: | October 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00435461 History of Changes |
Health Authority: | United States: Food and Drug Administration |
allergic rhinitis mountain cedar once daily fluticasone furoate fexofenadine |
Anti-Inflammatory Agents Neurotransmitter Agents Otorhinolaryngologic Diseases Anti-Asthmatic Agents Rhinitis Anti-Allergic Agents Histamine Hypersensitivity Terfenadine Histamine Antagonists Respiratory Tract Diseases |
Respiratory Tract Infections Rhinitis, Allergic, Seasonal Fexofenadine Hypersensitivity, Immediate Histamine phosphate Histamine H1 Antagonists Fluticasone Peripheral Nervous System Agents Bronchodilator Agents Respiratory Hypersensitivity |
Anti-Inflammatory Agents Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Rhinitis Hypersensitivity Respiratory Tract Infections Respiratory Tract Diseases Therapeutic Uses Fexofenadine Fluticasone Dermatologic Agents Otorhinolaryngologic Diseases Immune System Diseases |
Histamine Agents Anti-Asthmatic Agents Anti-Allergic Agents Nose Diseases Pharmacologic Actions Terfenadine Histamine Antagonists Autonomic Agents Rhinitis, Allergic, Seasonal Hypersensitivity, Immediate Histamine H1 Antagonists Peripheral Nervous System Agents Histamine H1 Antagonists, Non-Sedating Bronchodilator Agents Respiratory Hypersensitivity |